Whanin Pharmaceutical Co., Ltd. (016580)
Market Closed
15 Jun, 06:30
KRX SM KRX SM Primary ₩
10,240. 00
+20
+0.1957%
₩
173.74B Market Cap
- P/E Ratio
1,200% Div Yield
22,673 Volume
- Eps
₩ 10,220
Previous Close Want to track 016580 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Whanin Pharmaceutical Co., Ltd. (016580) Statistics
Valuation metrics
Market Cap 173.74B
Enterprise value 98.17B
Trailing P/E (ttm) 11.92
Forward P/E -
PEG ratio -0.43
Price/Sales (ttm) 0.59
Price/Book (mrq) 0.45
Enterprise Value/Revenue 0.37
Enterprise Value/EBITDA 4.27
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 36.33K
Average volume (90 days) 49.21K
Price summary
52-Week low 9,850
52-Week high 13,210
Beta -
50-Day moving average 10,881.56
200-Day moving average 10,824.89
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 300
Trailing annual dividend yield 0.0294%
5-Year annual dividend yield -
Payout ratio 0.29
Dividend Date 16 Apr 2026
Ex-Dividend Date 29 Dec 2025
Last split factor 2:1
Last split Date 14 Apr 2010
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.06%
Operating margin 0.06%
Operational effectiveness
Return on assets 0.03%
Return on equity 0.04%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 14,311.35
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 857.05
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 3,408.17
Total debt (mrq) -
Total Debt/Equity (mrq) 0
Current ratio (mrq) 4.1%
Book value per share (mrq) 22,803.36
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
